$1.79
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report
Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision
Overview
52-week range
$1.09
$4.19
23% of range
Avg surprise (last 3)
+3.9%
Avg reaction (last 2)
-4.5%
0% positive
Latest IV / EM
143%
EM ±10.4% · $3 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.33 | $-0.35 | +5.7% | +55.4% | -3.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.44 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.61 | $-0.69 | +11.6% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.74 | $-0.70 | -5.7% | — | -6.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-7.63 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.14 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.12 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.59 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.05 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.31 | -$0.61 | +49.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | — | $615,000 | $933,000 | $1M | — | $2M | $838,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-12M | — | $-15M | $-18M | $-42M | — | $-200M | $-21M |
| Net income | $-21M | — | $-24M | $-25M | $-47M | — | $-180M | $-25M |
| EPS (diluted) | $-0.33 | — | $-0.44 | $-0.61 | $-1.34 | — | $-7.63 | $-1.14 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $30M | $10M | $24M | $36M | $24M | $14M | $29M | $30M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $33M | $12M | $26M | $40M | $26M | $17M | $32M | $33M |
| Total assets | $324M | $305M | $330M | $346M | $335M | $350M | $368M | $553M |
| Long-term debt | $73,000 | $93,000 | $116,000 | $140,000 | $180,000 | $226,000 | $291,000 | $365,000 |
| Total liabilities | $289M | $283M | $278M | $272M | $261M | $252M | $247M | $246M |
| Total equity | $35M | $22M | $50M | $72M | $70M | $92M | $108M | $270M |